Skip to main content

Peer Review reports

From: Bevacizumab versus PARP-inhibitors in women with newly diagnosed ovarian cancer: a network meta-analysis

Original Submission
4 Jan 2022 Submitted Original manuscript
16 Jan 2022 Reviewed Reviewer Report
30 Jan 2022 Reviewed Reviewer Report - Mohammad Asif Sherwani
1 Feb 2022 Reviewed Reviewer Report
26 Feb 2022 Author responded Author comments - Banghyun Lee
1 Mar 2022 Author responded Author comments - Banghyun Lee
Resubmission - Version 2
26 Feb 2022 Submitted Manuscript version 2
3 Mar 2022 Author responded Author comments - Banghyun Lee
Resubmission - Version 3
3 Mar 2022 Submitted Manuscript version 3
13 Mar 2022 Reviewed Reviewer Report
14 Mar 2022 Reviewed Reviewer Report
22 Mar 2022 Reviewed Reviewer Report - Mohammad Asif Sherwani
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
23 Mar 2022 Editorially accepted
30 Mar 2022 Article published 10.1186/s12885-022-09455-x

You can find further information about peer review here.

Back to article page